15.1
IGC Pharma, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY25
FY22 – FY25
Assets
(positive)
Change from FY22 to FY25
millions USD
FY22:
FY23:
6.47
FY24:
3.71
FY25:
2.90
FY25:
1.79
(positive)
Change from FY22 to FY25
millions USD
FY22:
11.7
FY23:
10.7
FY24:
6.20
FY25:
5.85
FY25:
7.92
Total assets
Change from FY22 to FY25
millions USD
FY22:
26.8
FY23:
17.2
FY24:
9.90
FY25:
8.75
FY25:
9.71
Liabilities & Equity
(negative)
Change from FY22 to FY25
millions USD
FY22:
2.44
FY23:
1.90
FY24:
2.34
FY25:
2.26
FY25:
2.16
(negative)
Change from FY22 to FY25
millions USD
FY22:
0.50
FY23:
0.37
FY24:
0.24
FY25:
0.16
FY25:
0.13
(positive)
Change from FY22 to FY25
millions USD
FY22:
23.9
FY23:
14.9
FY24:
7.32
FY25:
6.33
FY25:
7.42
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
26.8
FY23:
17.2
FY24:
9.90
FY25:
8.75
FY25:
9.71
All amounts in millions USD